Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Dunkel

Showing results (181-190 of 237) with videos related to

Pageof 24
Sort By:
Pediatric Blood & Cancer|December 31, 2016
A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumorsOren J Becher, Stephen W Gilheeney, Yasmin Khakoo, et al.
Bone Marrow Transplantation|August 5, 2000
High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumorsV Papadakis, I J Dunkel, L D Cramer, et al.
Pediatric Blood & Cancer|September 20, 2008
Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: outcome compared with conventional chemotherapy: a report from the Children's Oncology GroupJonathan L Finlay, Girish Dhall, James M Boyett, et al.
The British Journal of Ophthalmology|October 27, 2018
Metastases and death rates after primary enucleation of unilateral retinoblastoma in the USA 2007-2017Jonathan E Lu, Jasmine H Francis, Ira J Dunkel, et al.
Ophthalmic Genetics|July 23, 1999
Intraocular carboplatin concentrations following intravenous administration for human intraocular retinoblastomaD H Abramson, C M Frank, G L Chantada, et al.
Pediatric Blood & Cancer|February 23, 2008
Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocolsGirish Dhall, Howard Grodman, Lingyun Ji, et al.
Cancer|January 13, 2016
Chronic medical conditions in adult survivors of retinoblastoma: Results of the Retinoblastoma Survivor StudyDanielle Novetsky Friedman, Joanne F Chou, Kevin C Oeffinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2019
Efficacy and Safety of Dabrafenib in Pediatric Patients with <i>BRAF</i> V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa StudyDarren R Hargrave, Eric Bouffet, Uri Tabori, et al.
Neuro-Oncology|March 30, 2016
Phase I trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A Pediatric Brain Tumor Consortium StudyRishi R Lulla, Stewart Goldman, Tohru Yamada, et al.
Palliative & Supportive Care|November 9, 2019
Impact of enucleation on adult retinoblastoma survivors' quality of life: A qualitative study of survivors' perspectivesSmita C Banerjee, Elaine Pottenger, Mary Petriccione, et al.
Pageof 24

Showing results (181-190 of 237) with videos related to

Sort By:
Pageof 24
Pediatric Blood & Cancer|December 31, 2016
A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumorsOren J Becher, Stephen W Gilheeney, Yasmin Khakoo, et al.
Bone Marrow Transplantation|August 5, 2000
High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumorsV Papadakis, I J Dunkel, L D Cramer, et al.
Pediatric Blood & Cancer|September 20, 2008
Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: outcome compared with conventional chemotherapy: a report from the Children's Oncology GroupJonathan L Finlay, Girish Dhall, James M Boyett, et al.
The British Journal of Ophthalmology|October 27, 2018
Metastases and death rates after primary enucleation of unilateral retinoblastoma in the USA 2007-2017Jonathan E Lu, Jasmine H Francis, Ira J Dunkel, et al.
Ophthalmic Genetics|July 23, 1999
Intraocular carboplatin concentrations following intravenous administration for human intraocular retinoblastomaD H Abramson, C M Frank, G L Chantada, et al.
Pediatric Blood & Cancer|February 23, 2008
Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the "Head Start" I and II protocolsGirish Dhall, Howard Grodman, Lingyun Ji, et al.
Cancer|January 13, 2016
Chronic medical conditions in adult survivors of retinoblastoma: Results of the Retinoblastoma Survivor StudyDanielle Novetsky Friedman, Joanne F Chou, Kevin C Oeffinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2019
Efficacy and Safety of Dabrafenib in Pediatric Patients with <i>BRAF</i> V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa StudyDarren R Hargrave, Eric Bouffet, Uri Tabori, et al.
Neuro-Oncology|March 30, 2016
Phase I trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A Pediatric Brain Tumor Consortium StudyRishi R Lulla, Stewart Goldman, Tohru Yamada, et al.
Palliative & Supportive Care|November 9, 2019
Impact of enucleation on adult retinoblastoma survivors' quality of life: A qualitative study of survivors' perspectivesSmita C Banerjee, Elaine Pottenger, Mary Petriccione, et al.
Pageof 24